Literature DB >> 20147565

A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors.

Jongrye Jeon1, Ditte Dencker, Gitta Wörtwein, David P D Woldbye, Yinghong Cui, Albert A Davis, Allan I Levey, Günther Schütz, Thomas N Sager, Arne Mørk, Cuiling Li, Chu-Xia Deng, Anders Fink-Jensen, Jürgen Wess.   

Abstract

Acetylcholine (ACh) regulates many key functions of the CNS by activating cell surface receptors referred to as muscarinic ACh receptors (M(1)-M(5) mAChRs). Like other mAChR subtypes, the M(4) mAChR is widely expressed in different regions of the forebrain. Interestingly, M(4) mAChRs are coexpressed with D(1) dopamine receptors in a specific subset of striatal projection neurons. To investigate the physiological relevance of this M(4) mAChR subpopulation in modulating dopamine-dependent behaviors, we used Cre/loxP technology to generate mutant mice that lack M(4) mAChRs only in D(1) dopamine receptor-expressing cells. The newly generated mutant mice displayed several striking behavioral phenotypes, including enhanced hyperlocomotor activity and increased behavioral sensitization following treatment with psychostimulants. These behavioral changes were accompanied by a lack of muscarinic inhibition of D(1) dopamine receptor-mediated cAMP stimulation in the striatum and an increase in dopamine efflux in the nucleus accumbens. These novel findings demonstrate that a distinct subpopulation of neuronal M(4) mAChRs plays a critical role in modulating several important dopamine-dependent behaviors. Since enhanced central dopaminergic neurotransmission is a hallmark of several severe disorders of the CNS, including schizophrenia and drug addiction, our findings have substantial clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147565      PMCID: PMC2824442          DOI: 10.1523/JNEUROSCI.3843-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

2.  G(olf)alpha mediates dopamine D1 receptor signaling.

Authors:  X Zhuang; L Belluscio; R Hen
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 3.  Genetic animal models: focus on schizophrenia.

Authors:  R R Gainetdinov; A R Mohn; M G Caron
Journal:  Trends Neurosci       Date:  2001-09       Impact factor: 13.837

4.  Elucidating the role of muscarinic receptors in psychosis.

Authors:  C C Felder; A C Porter; T L Skillman; L Zhang; F P Bymaster; N M Nathanson; S E Hamilton; J Gomeza; J Wess; D L McKinzie
Journal:  Life Sci       Date:  2001-04-27       Impact factor: 5.037

5.  Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice.

Authors:  Weilie Zhang; Masahisa Yamada; Jesus Gomeza; Anthony S Basile; Jürgen Wess
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

6.  Efficient FLP recombination in mouse ES cells and oocytes.

Authors:  J Schaft; R Ashery-Padan; F van der Hoeven; P Gruss; A F Stewart
Journal:  Genesis       Date:  2001-09       Impact factor: 2.487

Review 7.  Dopamine receptors in the learning, memory and drug reward circuitry.

Authors:  Jeffrey W Dalley; Barry J Everitt
Journal:  Semin Cell Dev Biol       Date:  2009-01-20       Impact factor: 7.727

8.  Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains.

Authors:  D C Rogers; D N Jones; P R Nelson; C M Jones; C A Quilter; T L Robinson; J J Hagan
Journal:  Behav Brain Res       Date:  1999-11-15       Impact factor: 3.332

Review 9.  D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action.

Authors:  Michele Hummel; Ellen M Unterwald
Journal:  J Cell Physiol       Date:  2002-04       Impact factor: 6.384

Review 10.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

View more
  65 in total

Review 1.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  CaMKII hunkers down on the muscarinic M4 receptor to help curb cocaine-induced hyperlocomotion.

Authors:  Ivar S Stein; Johannes W Hell
Journal:  EMBO J       Date:  2010-06-16       Impact factor: 11.598

3.  An allosteric enhancer of M₄ muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine.

Authors:  Ditte Dencker; Pia Weikop; Gunnar Sørensen; David P D Woldbye; Gitta Wörtwein; Jürgen Wess; Anders Fink-Jensen
Journal:  Psychopharmacology (Berl)       Date:  2012-05-31       Impact factor: 4.530

4.  Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.

Authors:  Morgane Thomsen; Simon Barak Caine
Journal:  Eur J Pharmacol       Date:  2016-02-11       Impact factor: 4.432

5.  Dopaminergic and cholinergic regulation of Fyn tyrosine kinase phosphorylation in the rat striatum in vivo.

Authors:  Li-Min Mao; John Q Wang
Journal:  Neuropharmacology       Date:  2015-08-13       Impact factor: 5.250

6.  δ-opioid and dopaminergic processes in accumbens shell modulate the cholinergic control of predictive learning and choice.

Authors:  Vincent Laurent; Jesus Bertran-Gonzalez; Billy C Chieng; Bernard W Balleine
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

7.  Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.

Authors:  Anders Fink-Jensen; Lene S Schmidt; Ditte Dencker; Christina Schülein; Jürgen Wess; Gitta Wörtwein; David P D Woldbye
Journal:  Eur J Pharmacol       Date:  2011-01-24       Impact factor: 4.432

8.  Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice.

Authors:  Gunnar Sørensen; Morten Jensen; Pia Weikop; Ditte Dencker; Søren H Christiansen; Claus Juul Loland; Cecilie Hee Bengtsen; Jørgen Holm Petersen; Anders Fink-Jensen; Gitta Wörtwein; David P D Woldbye
Journal:  Psychopharmacology (Berl)       Date:  2012-02-25       Impact factor: 4.530

Review 9.  Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling.

Authors:  Daniel J Foster; Carrie K Jones; P Jeffrey Conn
Journal:  Discov Med       Date:  2012-12       Impact factor: 2.970

10.  Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways).

Authors:  Rachel J Smith; Mary Kay Lobo; Sade Spencer; Peter W Kalivas
Journal:  Curr Opin Neurobiol       Date:  2013-02-18       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.